Why don't we hold management accountable when they fail to get FDA approval? Despite the CEOs salary being roughly the same as the annual revenue?
Or how about considering PNV managed to achieve decent growth despite the headwinds of Covid, while that other company struggled, even though it's product was being touted as a potential Covid treatment.
Just because they're at different stages doesn't mean you should give one a free pass. Don't forget, they're at very different stages but at same market caps.
And one argument is that the potential for the other company is much greater because they could treat so many diseases? Sure, in theory. But they're using the kitchen sink method, where they have a product with no proven use, and are throwing it at everything to see if it will stick. That's a pretty high risk way to develop a product.
I didn't want to turn this into a thread comparing the two. I just wanted to point out that we all have our own biases.
I'm glad management increased hiring. Now that Covid is ramping down, we already have boots on the ground getting trained. If you had it your way, they would now be scrambling to try and hire, and we would be behind the curve.
Just think about the strategy you are recommending. They don't need a cap raise at this stage, so what's the harm in spending the money to ramp up sales? You make so much sense sometimes, but I just don't understand this line of thinking.
(20min delay)